Attached files
| file | filename |
|---|---|
| 8-K - 8-K CURRENT REPORT - INNOVUS PHARMACEUTICALS, INC. | v300965_8k.htm |
February 1, 2012
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Ladies and Gentlemen:
We have read the statements of Innovus Pharmaceuticals, Inc. (Formerly North Horizon, Inc.) pertaining to our firm included under Item 4.01 of Form 8-K, to be filed on or about February 1, 2012 and agree with such statements as they pertain to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein.
Sincerely,
/s/ Pritchett, Siler & Hardy, P.C.
PRITCHETT, SILER & HARDY, P.C.